Cagrilintide has been characterized in peer-reviewed research and clinical investigation as a potent, selective amylin receptor agonist with an extended pharmacokinetic profile suitable for once-weekly dosing paradigms
Disclaimer: As a service to our readers, Harvard Health Publishing provides access to our library of archived content
Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, et al
Topical use presents lower theoretical risk but should still be discussed with a healthcare provider
These commenters requested that we assign CPT code 97008 to APC 1506 (New TechnologyLevel 6 ($401-$500)) and status indicator S instead of the proposed status indicator N. The commenter stated that there is no service to which CPT code 97008 can be packaged into, while also explaining that it is reported once for each chemotherapy session for an average of 5 to 7 sessions per patient

TIER 0 (25mg total) $249 total for 8-10 week supply Monthly cost breakdown: $99 Recommended if using low (or micro) doses of 2mg/week or less TIER 1 (50mg total) $345 total for 10 week supply Monthly cost breakdown: $138 Recommended if new to treatment or for those on 2-5mg/week TIER 2 (75mg total) $399 total for 8-10 week supply Monthly cost breakdown: $159-$199 based on weekly dose Recommended for those on 6-9mg/week TIER 3 (100mg total) $475 total for 8-10 week supply Monthly cost breakdown: $190-$237 based on weekly dose Recommended for those on 10-12mg/week TIER 4 (141mg total) $599 total for 9-10 week supply Monthly cost breakdown: $239-$266 based on weekly dose Recommended for those on 13mg/week and up Empower Pharmacy - Tirzepatide/Niacinamide Injection Up to 70 days BUD